HTG Molecular Diagnostics (NASDAQ:HTGM) will be announcing its earnings results after the market closes on Monday, May 14th.
HTG Molecular Diagnostics (NASDAQ:HTGM) last released its earnings results on Thursday, March 22nd. The medical research company reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.30) by $0.15. The firm had revenue of $7.90 million for the quarter, compared to the consensus estimate of $7.05 million.
NASDAQ HTGM opened at $3.68 on Monday. HTG Molecular Diagnostics has a 12 month low of $1.59 and a 12 month high of $5.83. The company has a market cap of $104.35, a price-to-earnings ratio of -2.06 and a beta of 1.61.
About HTG Molecular Diagnostics
HTG Molecular Diagnostics, Inc develops and markets products and services based on proprietary technology that facilitates the routine use of targeted molecular profiling. The company's products, HTG Edge and HTG EdgeSeq platforms include instrumentation (or platforms), consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies.
Receive News & Ratings for HTG Molecular Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HTG Molecular Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.